← Back to Search

Lottery Incentive Program for High Blood Pressure (BETTER-BP Trial)

N/A
Recruiting
Led By John Dodson
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A diagnosis of hypertension.
1 ambulatory systolic blood pressure ≥140 mmHg (on therapy).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, and 12 months
Awards & highlights

BETTER-BP Trial Summary

This trial is designed to improve regulation of blood pressure by using a lottery incentive program to promote adherence to antihypertensive medication delivered via smartphone.

Who is the study for?
The BETTER-BP trial is for individuals with high blood pressure who have been less than 80% adherent to their antihypertensive medication. Participants must have at least one blood pressure reading of ≥140 mmHg, a hypertension diagnosis, and be on prescribed medication like thiazide diuretics or ACE inhibitors. It's not for pregnant individuals, those unable to use the study app in English/Spanish, with technology barriers due to sensory impairments, incarceration, or life expectancy under 12 months.Check my eligibility
What is being tested?
This phase II trial tests if a 'regret lottery' incentive program delivered via smartphone can improve adherence to blood pressure medications over six months. Of the 435 patients recruited from NYC clinics with poor adherence records, two-thirds will receive this intervention while the rest are in control condition without incentives.See study design
What are the potential side effects?
Since this trial focuses on behavioral incentives rather than new medications or treatments, there aren't direct side effects from interventions being tested. However, participants may experience stress or disappointment if they do not win in the lottery.

BETTER-BP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with high blood pressure.
Select...
My blood pressure is 140 mmHg or higher, even with medication.
Select...
I often forget to take my medication as prescribed.
Select...
I am currently taking medication for high blood pressure.

BETTER-BP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Change in Systolic Blood Pressure (SBP)
Other outcome measures
Comorbidity burden will be evaluated (baseline) using the Charlson Comorbidity Index (CCI)
Depression will be measured (baseline) by the PHQ-9
Motivation measured with the Treatment Self-Regulation Questionnaire (TSRQ)
+2 more

BETTER-BP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Regret lotteryExperimental Treatment1 Intervention
Will receive a lottery incentive ("regret lottery") for 6 months
Group II: Control ConditionPlacebo Group1 Intervention
Will complete a total of 3 in-person study visits, approximately one hour each.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Regret Lottery
2009
N/A
~640

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,363 Previous Clinical Trials
815,981 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,820 Previous Clinical Trials
47,299,002 Total Patients Enrolled
John DodsonPrincipal InvestigatorNew York Langone Health

Media Library

Regret Lottery Clinical Trial Eligibility Overview. Trial Name: NCT04114669 — N/A
High Blood Pressure Research Study Groups: Regret lottery, Control Condition
High Blood Pressure Clinical Trial 2023: Regret Lottery Highlights & Side Effects. Trial Name: NCT04114669 — N/A
Regret Lottery 2023 Treatment Timeline for Medical Study. Trial Name: NCT04114669 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open positions available in this research endeavor?

"Affirmative. As evidenced by the information hosted on clinicaltrials.gov, this medical experiment is still recruiting 435 participants from a single research centre; its original posting was July 14th 2020 and it has been updated as recently as July 28th 2022."

Answered by AI

To what extent has the participant pool been augmented for this medical trial?

"Yes, the clinical trial is still recruiting. According to records on clinicaltrials.gov, this medical study was initially shared on July 14th 2020 and was recently refreshed on 28th of July 2022. Currently 435 patients need to be enrolled from 1 participating hospital facility."

Answered by AI

Who else is applying?

What state do they live in?
California
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~93 spots leftby Mar 2025